SNAI1 and intestinal cancer: To assess the impact of SNAIL on tumour development, progression and survival of intestinal cancer, where SNAIL is aberrantly expressed in 78% of cases18, we used three different genetically engineered models that mirror major histopathological and molecular disease subtypes19–21 (Fig. 2 and Supplementary Fig. S2).